Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 4

The effect of baicalein on Wnt/β-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line

Pages
1168–1179
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study aimed toinvestigate the effect of baicalein and miR-25 on Wnt/β-catenin signaling pathway of osteosarcoma cell line Saos-2.Materials and methods: Cell viability was assessed, and qRT-PCR and Western blot were performed to study the effects of baicalein onexpression of Wnt/β-catenin signaling pathway-realted genes (β-catenin, GSK-3β, and Axin2) of Saos-2 cells.Results: Our results indicated that baicalein can inhibit the proliferation $(IC_{50}$ value 35 µM), regulate Wnt/β-catenin pathway and alsoincrease miR-25 expression of Saos-2.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aim: Osteosarcoma is the most common primary bone malignancy that occurs frequently in children and adolescents.Baicalein, a flavonoid that has attracted great attention in recent years with its strong antitumor activity, shows a wide range of biologicaland pharmaceutical effects.MicroRNAs have been found to be involved in many critical processes in cancers.
📊
Key Findings & Data:This study aimed toinvestigate the effect of baicalein and miR-25 on Wnt/β-catenin signaling pathway of osteosarcoma cell line Saos-2.Materials and methods: Cell viability was assessed, and qRT-PCR and Western blot were performed to study the effects of baicalein onexpression of Wnt/β-catenin signaling pathway-realted genes (β-catenin, GSK-3β, and Axin2) of Saos-2 cells.Results: Our results indicated that baicalein can inhibit the proliferation $(IC_{50}$ value 35 µM), regulate Wnt/β-catenin pathway and alsoincrease miR-25 expression of Saos-2.
💡
Conclusion & Impact:Down regulation of miR-25 decreased the expression of GSK-3β, while β-catenin and Axin2 expressionincreased.Conclusion: These findings demonstrate that baicalein may target genes related to the Wnt/β-catenin pathway by regulating miR-25expression and may be a potential Wnt/β-catenin pathway inhibitor for osteosarcoma therapy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aim: Osteosarcoma is the most common primary bone malignancy that occurs frequently in children and adolescents.Baicalein, a flavonoid that has attracted great attention in recent years with its strong antitumor activity, shows a wide range of biologicaland pharmaceutical effects.MicroRNAs have been found to be involved in many critical processes in cancers. This study aimed toinvestigate the effect of baicalein and miR-25 on Wnt/β-catenin signaling pathway of osteosarcoma cell line Saos-2.Materials and methods: Cell viability was assessed, and qRT-PCR and Western blot were performed to study the effects of baicalein onexpression of Wnt/β-catenin signaling pathway-realted genes (β-catenin, GSK-3β, and Axin2) of Saos-2 cells.Results: Our results indicated that baicalein can inhibit the proliferation $(IC_{50}$ value 35 µM), regulate Wnt/β-catenin pathway and alsoincrease miR-25 expression of Saos-2. Baicalein and also miR-25 decreased the expression of β-catenin and Axin2, while increasingthe expression of GSK-3β. Down regulation of miR-25 decreased the expression of GSK-3β, while β-catenin and Axin2 expressionincreased.Conclusion: These findings demonstrate that baicalein may target genes related to the Wnt/β-catenin pathway by regulating miR-25expression and may be a potential Wnt/β-catenin pathway inhibitor for osteosarcoma therapy

🔖

Cite This Article

YAYLAGÜL, E. Ö., ÜLGER, C. (2022). The effect of baicalein on Wnt/β-catenin pathway and miR-25 expression in Saos-2 osteosarcoma cell line. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 4, 1168–1179. https://ajindex.com/articles/609643

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Broadhead ML, Clark JCM, Myers D, Dass CR, Choong PFM. The molecular pathogenesis of osteosarcoma: a review. Sarcoma 2011
  2. doi: 10.1155/2011/959248 2. Amado NG, Fonseca BF, Cerqueira DM, Neto VM, Abreu JG. Flavonoids: potential Wnt/β-catenin signaling modulators in cancer. Life Sciences 2011
  3. doi: 10.1016/j. lfs.2011.05.003 3. Park S, Choi J. Inhibition of β-catenin/Tcf signaling by flavonoids. Journal of Cellular Biochemistry 2010
  4. doi: 10.1002/jcb.22654 4. Chen J, Li Z, Chen AY, Ye X, Luo H et al. Inhibitory effect of baicalin and baicalein on ovarian cancer cells. International Journal of Molecular Sciences 2013
  5. 14 (3): 6012-6025. doi: 10.3390/ijms14036012 5. Ye F, Wang H, Zhang L, Zou Y, Han H et al. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROSinduced BNIP3 expression. Tumor Biology 2015
  6. doi: 10.1007/s13277-015-3122-y 6. Guo Z, Hu X, Xing Z, Xing R, Lv R et al. Baicalein inhibits prostate cancer cell growth and metastasis via the caveolin-1/ AKT/mTOR pathway. Molecular and Cellular Biochemistry 2015
  7. doi: 10.1007/s11010-015-2429-8 7. Li HL, Zhang S, Wang Y, Liang RR, Li J et al. Baicalein induces apoptosis via a mitochondrial-dependent caspase activation pathway in T24 bladder cancer cells. Molecular Medicine Reports 2013
  8. doi: 10.3892/mmr.2012.1123 8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004
  9. doi: 10.1016/s0092- 8674(04)00045-5 9. Miao J, Wu S, Peng Z, Tania M, Zhang C. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects. Tumor Biology 2013
  10. doi: 10.1007/s13277-013-0940-7 10. Kumar RMR, Boro A, Fuchs B. Involvement and clinical aspects of MicroRNA in osteosarcoma. International Journal of Molecular Sciences 2016
  11. doi: 10.3390/ijms17060877 11. Xu Z, Li C, Qu H, Li H, Gu Q et al. MicroRNA-195 inhibits the proliferation and invasion of pancreatic cancer cells by targeting the fatty acid synthase/Wnt signaling pathway. Tumour Biology 2017
  12. 39 (6): 1010428317711324. doi: 10.1177/1010428317711324 12. Li H, Zhang K, Liu LH, Ouyang Y, Guo HB et al. MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma. Oncology Letters 2015
  13. doi: 10.3892/ol.2015.3378 13. Zhu S, Pan W, Qian Y. MicroRNA in immunity and autoimmunity. Journal of Molecular Medicine 2013
  14. doi: 10.1007/s00109-013-1043-z 14. Bian S. and Sun